FOXBOROUGH – On Monday night, the Patriots shed a little light on the health status of defensive lineman Armond Armstead, who is currently on the non-football illness list.
The team released a statement that said, “Armond Armstead had surgery to treat an infection. Armond is in good condition and is expected to make a full recovery. A timetable has not been set for his return.”
Coach Bill Belichick was asked Sunday if Armstead’s absence is related to his previous health problems – he suffered a heart attack while a player at Southern California which he has blamed on injections of the pain medication Toradol that he did not ask for – and Belichick said he believed it to be a different situation and “if we have anything, we’ll talk about it, but not at this time.”
Once projected as a first- to second-round pick, Armstead’s heart attack in March 2011 changed his status with NFL teams. When he was not allowed to return to the field at USC, he entered the 2012 draft but was not selected or signed as a free agent.
Instead, he played last fall in the CFL, for Toronto, was named a league All-Star and was one of the top defensive players on an Argonauts team that won the Grey Cup. He signed a three-year deal with the Patriots in January.
Armstead is suing the USC team physician, University Park Health Center, and an unnamed pharmaceutical company for unspecified damages, claiming the improperly administered Toradol injections caused the heart attack and affected his NFL career.